Nothing Special   »   [go: up one dir, main page]

GB0614365D0 - Pharmaceutical compositions and their use - Google Patents

Pharmaceutical compositions and their use

Info

Publication number
GB0614365D0
GB0614365D0 GBGB0614365.5A GB0614365A GB0614365D0 GB 0614365 D0 GB0614365 D0 GB 0614365D0 GB 0614365 A GB0614365 A GB 0614365A GB 0614365 D0 GB0614365 D0 GB 0614365D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0614365.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
PROAXON Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROAXON Ltd filed Critical PROAXON Ltd
Priority to GBGB0614365.5A priority Critical patent/GB0614365D0/en
Publication of GB0614365D0 publication Critical patent/GB0614365D0/en
Priority to PCT/GB2007/002722 priority patent/WO2008009935A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0614365.5A 2006-07-19 2006-07-19 Pharmaceutical compositions and their use Ceased GB0614365D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0614365.5A GB0614365D0 (en) 2006-07-19 2006-07-19 Pharmaceutical compositions and their use
PCT/GB2007/002722 WO2008009935A1 (en) 2006-07-19 2007-07-19 Pharmaceutical compositions and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0614365.5A GB0614365D0 (en) 2006-07-19 2006-07-19 Pharmaceutical compositions and their use

Publications (1)

Publication Number Publication Date
GB0614365D0 true GB0614365D0 (en) 2006-08-30

Family

ID=36998366

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0614365.5A Ceased GB0614365D0 (en) 2006-07-19 2006-07-19 Pharmaceutical compositions and their use

Country Status (2)

Country Link
GB (1) GB0614365D0 (en)
WO (1) WO2008009935A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011027812A1 (en) * 2009-09-04 2011-03-10 株式会社 資生堂 Method for producing o/w cream having high viscosity
WO2013043744A2 (en) 2011-09-21 2013-03-28 Inception 1, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
TW201434832A (en) * 2013-02-12 2014-09-16 Univ Kyushu Nat Univ Corp Compound, light-emitting material and organic electroluminescence device
TW201536795A (en) 2013-05-31 2015-10-01 Medeia Therapeutics Ltd Use of arylthiazine compounds as cytoprotectants
CN104109134A (en) * 2014-06-26 2014-10-22 陕西科技大学 N-acyl phenothiazine and preparation method thereof
JP7471818B2 (en) 2016-08-18 2024-04-22 ヴィダック ファーマ リミテッド Piperazine derivatives, pharmaceutical compositions, and methods of use thereof
CN107043345B (en) * 2017-06-20 2019-07-05 齐鲁工业大学 4-acetylbiphenyl hydrazone-indoline -2,3- diketone Schiff base preparation, structure and purposes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430091A1 (en) * 1994-08-25 1996-02-29 Bayer Ag Use of N-substituted phenothiazines
FR2784678B1 (en) * 1998-09-23 2002-11-29 Sod Conseils Rech Applic NOVEL N- (IMINOMETHYL) AMINE DERIVATIVES, THEIR PREPARATION, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PL200167B1 (en) * 1999-11-05 2008-12-31 Sod Conseils Rech Applic Novel heterocyclic compounds and their use as medicines
CA2310205A1 (en) * 2000-05-29 2001-11-29 Dalhousie University Unknown
FR2835254B1 (en) * 2002-01-25 2006-04-07 Sod Conseils Rech Applic THIAZOLE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISEASES
FR2863268B1 (en) * 2003-12-09 2006-02-24 Sod Conseils Rech Applic NOVEL DERIVATIVES OF 2-HYDROXYTETRAHYDROFURAN AND THEIR APPLICATION AS MEDICAMENTS

Also Published As

Publication number Publication date
WO2008009935A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
IL242883B (en) Arylamino- and heteroarylamino-substituted dioxoazolines and pharmaceutical compositions comprising them
EP2056835A4 (en) Pharmaceutical compositions and uses thereof
IL194546A0 (en) Arylaminopyridine derivatives and pharmaceutical compositions containing them
IL192613A (en) Cycloalkylamines and pharmaceutical compositions comprising same
EP2001498A4 (en) Pharmaceutical compositions
IL194176A0 (en) Pharmaceutical compositions
EP1890677A4 (en) Pharmaceutical compositions and use thereof
GB0625322D0 (en) Pharmaceutical compositions
IL204442A (en) F1f0-atpase inhibitors, pharmaceutical compositions comprising them and use thereof
HK1138732A1 (en) Pharmaceutical compositions
GB0617191D0 (en) Improvements in pharmaceutical compositions
EP2154966A4 (en) Benzimidazoles and pharmaceutical compositions thereof
IL206594A (en) Azinone-tetrahydropyridoindole derivatives and pharmaceutical compositions comprising thereof
IL193211A (en) Indazole-heteroaryl derivatives and pharmaceutical compositions comprising them
GB0614586D0 (en) Pharmaceutical Formulation
GB0610090D0 (en) Particulate drug compositions and their uses
EP2070919A4 (en) Spiroquinone compound and pharmaceutical composition
PL2012805T3 (en) Therapeutic composition and use
GB0614365D0 (en) Pharmaceutical compositions and their use
EP2029132A4 (en) Anti-histamine compositions and use thereof
EP1998753A4 (en) High-deposition compositions and uses thereof
EP2124959A4 (en) Pharmaceutical composition
EP1937292A4 (en) Lopap-based pharmaceutical compositions and uses thereof
EP2114404A4 (en) Pharmaceutical compound and composition
IL189827A0 (en) Pharmaceutical dosage forms and compositions comprising lecoztan

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: UCL BUSINESS PLC

Free format text: FORMER APPLICANT(S): PROAXON LTD

AT Applications terminated before publication under section 16(1)